Sno | Generic Name | Dosage Form |
01 |
Cetrimide Cream BP 0.5% w/w |
Each Composion: Contains:
Cetrimide BP: | 0.5% w/w |
Cream Base : | q. s. |
|
02 |
Chloroxylenol Cream 0.8% w/w |
Each Composion: Contains:
Chloroxylenol BP : | 0.8% w/w |
Cream Base : | q. s. |
|
03 |
Ciprofloxacin Cream 0.5% w/w |
Each Composion: Contains: Ciprofloxacin Hydrochloride BP
Eq. to Ciprofloxacin : | 0.5% w/w |
Cream Base | q.s. |
|
04 |
Ciprofloxacin with Fluocinolone
& Clotrimazole Cream |
Each Composion: Contains: Ciprofloxacin Hydrochloride BP
Dextrose Anhydrous BP : | 20.000 g |
Eq. to Ciprofloxacin : | 0.5% w/w |
Fluocinolone Acetonide BP : | 0.025% w/w |
Clotrimazole BP : | 1% w/w |
Cream Base | q.s. |
|
05 |
Diclofenac Diethylamine,
Methyl Salicylate, Menthol,
Linseed Oil and Capsaicin Gel |
Each Composion: Contains:
Diclofenac Diethylamine BP : | 1.160% w/w |
Eq. To Diclofenac Sodium : | 1.000% w/w |
Linseed Oil BP : | 3.000% w/w |
Methyl Salicylate BP : | 10.000% w/w |
Menthol BP : | 5.000% w/w |
Capsaicin USP : | 0.025% w/w |
Benzyl Alcohol BP (As Preservative) : | 1.000% w/w |
Aqueous Gel Base | Q. S. |
|
06 |
Diclofenac with Methyl
Salicylate, Oleum Lini, Menthol
& Linseed Oil Gel (For Export) |
Each Composition: Contains:
Diclofenac Diethylamine BP : | 1.160% w/w |
Eq. To Diclofenac Sodium : | 1.000% w/w |
Oleum Lini (Contains predominantly alpha
Linolenic Acid ) : | 3.000% w/w |
Methyl Salicylate BP : | 10.000% w/w |
Menthol BP : | 5.000% w/w |
Benzyl Alcohol BP (As Preservative) : | 1.000% w/w |
Aqueous Gel Base | Q. S. |
|
07 |
Fluocinolone Cream BP
0.025% w/w (For Export) |
Each Composition: Contains:
Fluocinolone Acetonide BP : | 0.025 % w/w |
Cream base | Q. S. |
|
08 |
Fluocinolone Ointment BP
0.01% w/w (For Export) |
Each Composition: Contains:
Fluocinolone Acetonide BP : | 0.01 % w/w |
Ointment base | Q. S. |
|
09 |
Fusidic Acid Cream BP
2% w/w (For Export) |
Each Composition: Contains:
Fusidic Acid BP : | 2% w/w |
Cream base | Q. S. |
|
10 |
Hydroquinone Cream USP
4% w/w (For Export) |
Each Composition: Contains:
Hydroquinone USP : | 4% w/w |
Cream base | Q. S. |
|
11 |
Ketoconazole Cream BP 2%
(For Export) |
Each Composition: Contains:
Ketoconazole BP : | 2% w/w |
Cream base | Q. S. |
|
12 |
Methyl Salicylate, Eucalyptus
Oil, Turpentine Oil and
Menthol Gel
(For Export) |
Each Composition: Contains:
Methyl Salicylate BP : | 15.000% w/w |
Eucalyptus Oil BP : | 7.000% w/w |
Turpentine Oil BP : | 1.500% w/w |
Menthol BP: | 6.000% w/w |
Aqueous Gel Base | Q. S. |
|
13 |
Nimesulide Gel 1% w/w
(For Export) |
Each Composition: Contains:
Nimesulide BP : | 1.000% w/w |
Gel base | Q. S. |
|
14 |
Nitrofurazone Ointment USP
0.2% w/w (For Export) |
Each Composition: Contains:
Nitrofurazone USP | 0.200% w/w |
Chlorocresol BP | 0.100% w/w |
Cream base | Q. S. |
|
15 |
Piroxicam Gel BP
(For Export) |
Each Composition: Contains:
Piroxicam BP | 0.5% w/w |
Gel base | Q. S. |
|
16 |
Povidone Iodine with
SucralfateOintment
(For Export) |
Each Composition: Contains:
Povidone Iodine BP | 5.000% w/w |
(Available Iodine | 0.5% w/w ) |
Sucralfate BP | 7.000% w/w |
Water Soluble Ointment Base | Q. S. |
|
17 |
Salicylic Acid Ointment BP
2% w/w (For Export) |
Each Composition: Contains:
Salicylic Acid BP | 2% w/w |
(Available Iodine | 0.5% w/w ) |
Ointment Base | Q. S. |
|
18 |
Povidone Iodine with
Metronidazole & Aloe Ointment
(For Export) |
Each Composition: Contains:
Povidone Iodine BP | 5.000% w/w |
(Available Iodine | 0.5% w/w) |
Metronidazole BP | 1.000% w/w |
Aloe | 1.500% w/w |
Water Soluble Ointment Base | Q. S. |
|
19 |
Silver Sulphadiazine with
Chlorhexidine Gluconate Cream
(For Export) |
Each Composition: Contains:
Silver Sulphadiazine USP | 1.000% w/w |
Chlorhexidine Gluconate Solution BP | 2.000% w/w |
Cream Base | Q. S. |
|
20 |
Silver Sulphadiazine with
Chlorhexidine Hydrochloride
Cream (For Export) |
Each Composition: Contains:
Silver Sulphadiazine BP | 1.000% w/w |
Chlorhexidine Hydrochloride BP | 0.500% w/w |
Cream Base | Q. S. |
|
21 |
Sulphur Ointment 10% w/w
(For Export) |
Each Composition: Contains:
Sulphur Sublimed | 10.000% w/w |
Petroleum Jelly to Make | Q. S. |
|
22 |
Tacrolimus Ointment 0.1%w/w
(For Export) |
Each Composition: Contains:
Tacrolimus USP | 0.10% w/w |
Ointment base | Q. S. |
|
23 |
Salicylic Acid, Benzoic Acid,
Oil Citronella & Thymol
Ointment (For Export) |
Each 15 g. Contains:
Salicylic Acid BP | 0.950 gm |
Benzoic Acid BP | 0.250 gm |
Thymol BP | 0.050 gm |
Oil Citronella | 0.100 gm |
Petroleum Jelly Base | Q. S. |
|
24 |
Sucralfate, Metronidazole and
Povidone Iodine Ointment
(For Export) |
Each gm. Contains:
Sucralfate USP | 70 mg |
Metronidazole BP | 10 mg |
Povidone Iodine BP | 50 mg |
Ointment Base | Q. S. |
|
25 |
White Soft Paraffin and Liquid
Paraffin Cream |
Each Composition: Contains:
White Soft Paraffin BP | 13.200% w/w |
Liquid Paraffin BP | 10.200% w/w |
Cream Base | Q. S. |
|
26 |
Zinc Cream BP 32% w/w
(For Export) |
Each Composition: Contains:
Zinc Oxide BP | 32.000% w/w |
Cream Base | Q. S. |
|
27 |
Whitfield’s Ointment
(Compound Benzoic Acid
Ointment ) BP (For Export) |
Each Composition: Contains:
Benzoic Acid BP | 6% w/w |
Salicylic Acid BP | 3% w/w |
Ointment Base | Q. S. |
|
28 |
Silver Sulfadiazine Cream USP
1%w/w (For Export) |
Each Composition: Contains:
Silver Sulfadiazine USP | 1% w/w |
Methyl Paraben BP (Preservatives) | 0.165%w/w |
Propyl Paraben BP (Preservatives) | 0.077%w/w |
Cream Base | Q. S. |
|
29 |
Povidone Iodine Ointment USP
5% w/w (For Export) |
Each Composition: Contains:
Povidone Iodine USP | 5% w/w |
(Available Iodine | 0.5%w/w ) |
Water Soluble Ointment Base | Q. S. |
|
30 |
Clotrimazole Cream BP 2% w/w
(For Export) |
Each Composition: Contains:
Clotrimazole BP | 2% w/w |
Cream Base | Q. S. |
|
31 |
Miconazole Cream BP 2% w/w
(For Export) |
Each Composition: Contains:
Miconazole Nitrate BP | 2% w/w |
Cream Base | Q. S. |
|
32 |
Clotrimazole Cream BP 1% w/w
(For Export) |
Each Composition: Contains:
Clotrimazole BP | 1% w/w |
Cream Base | Q. S. |
|
33 |
Diclofenac Gel BP 1% w/w
(For Export) |
Each Composition: Contains:
Diclofenac Diethylamine BP | 1.16 % w/w |
Equivalent to Diclofenac Sodium | 1% w/w |
Aqueous Gel Base | Q. S. |
|
34 |
Povidone Iodine and
Ornidazole Ointment
(For Export) |
Each Composition: Contains:
Povidone Iodine USP | 5% w/w |
(Available iodine | 0.5% w/w) |
Ornidazole IP | 1% w/w |
Water soluble ointment base | Q. S. |
|
35 |
Povidone-Iodine and
Metronidazole Ointment
(For Export) |
Each Composition: Contains:
Povidone Iodine USP | 5% w/w |
(Available iodine | 0.5% w/w) |
Metronidazole BP | 1% w/w |
Ointment base | Q. S. |
|
36 |
Nitrofurazone and
Chlorocresol Cream
(For Export) |
Each Composition: Contains:
Nitrofurazone USP | 0.2 % w/w |
Chlorocresol USP | 0.1 % w/w |
Cream base | Q. S. |
|
37 |
Povidone Iodine Ointment USP
10 % w/w (For Export) |
Each Composition: Contains:
Povidone Iodine USP | 10 % w/w |
awailable Iodine | 1.0% w/w |
Water Soluble Ointment Base | Q. S. |
|
38 |
Povidone Iodine Ointment USP
10 % w/w (For Export) |
Each Composition: Contains:
Povidone Iodine USP | 10 % w/w |
awailable Iodine | 1.0% w/w |
Water Soluble Ointment Base | Q. S. |
|
39 |
Aciclovir Cream B.P.
(For Export) |
Each Composition: Contains:
Aciclovir BP | 5.000% w/w |
Cream Base | Q. S. |
|
40 |
Beclomethasone Cream BP
0.025 % w/w (For Export) |
Each Composition: Contains:
Beclomethasone Dipropionate BP | 0.025 % w/w |
Cream Base | Q. S. |
|
41 |
Beclometasone with
Clotrimazole Cream
(For Export) |
Composition:
Clotrimazole BP | 1.000 % w/w |
Beclomethasone Dipropionate BP | 0.025% w/w |
Cream Base | Q. S. |
|
42 |
Beclometasone with
Neomycin Cream
(For Export) |
Composition:
Beclometasone Dipropionate BP | 0.025% w/w |
Neomycin Sulfate USP | 0.500% w/w |
Eq. To Neomycin Base | 0.350% w/w |
Cream Base | Q. S. |
|
43 |
Beclometasone with
Salicylic Acid Cream
(For Export) |
Composition:
Beclometasone Dipropionate BP | 0.025% w/w |
Salicylic Acid BP | 3.000% w/w |
Cream Base | Q. S. |
|
44 |
Beclometasone, Gentamicin &
Clotrimazole Cream
(For Export) |
Composition:
Beclometasone Dipropionate BP | 0.025% w/w |
Gentamicin Sulfate BP Eq. To. Gentamicin | 0.100% w/w |
Clotrimazole BP | 1.000% w/w |
Cream Base | Q. S. |
|
45 |
Betamethasone Diporpionate
Cream USP 0.050% w/w
(For Export) |
Composition:
Betamethasone Dipropionate USP
Eq. To Betamethasone | 0.050% w/w |
Cream Base | Q. S. |
|
46 |
Betamethasone Valerate
Ointment BP 0.12 % w/w
(For Export) |
Composition:
Betamethasone Valerate BP | 0.120% w/w |
Ointment Base | Q. S. |
|
47 |
Betamethasone Valerate
Ointment BP 0.025% w/w
(For Export) |
Composition:
Betamethasone Valerate BP | 0.025% w/w |
Ointment Base | Q. S. |
|
48 |
Betamethasone Valerate
Cream BP 0.1 % w/w
(For Export) |
Each Composition:Contains:
Betamethasone Valerate BP | 0.100% w/w |
Chlorocresol BP (As preservative) | 0.1% w/w |
Cream Base | Q. S. |
|
49 |
Betamethasone with
Salicylic Acid Ointment
(For Export) |
Composition:
Betamethasone Dipropionate BP Eq. to Betamethasone | 0.050% w/w |
Salicylic Acid BP | 3.000% w/w |
Ointment Base | Q. S. |
|
50 |
Clindamycin Phosphate &
Tretinoin gel
(For Export) |
Each Composition Contains:
Clindamycin Phosphate BP eq. to Clindamycin | 1.000% w/w |
Tretinoin BP | 0.025% w/w |
Gel Base | Q. S. |
|
51 |
Clindamycin Phosphate Gel
USP 1 % w/w
(For Export) |
Each Composition Contains:
Clindamycin Phosphate BP Eq. To Clindamycin | 1.000% w/w |
Gel Base | Q. S. |
|
52 |
Clobetasol Cream BP
0.05 % w/w
(For Export) |
Each Composition Contains:
Clobetasol Propionate BP | 0.5 % w/w |
Cream Base | Q. S. |
|
53 |
Beclometasone Dipropionate,
Gentamicin, Tolnaftate &
Iodochlorhydroxyquinoline
Cream (For Export) |
Each Composition Contains:
Beclometasone Dipropionate BP | 0.025% w/w |
Gentamicin (as Sulfate) BP | 0.100 % w/w |
Iodochlorhydroxyquinoline BP | 1.000% w/w |
Tolnaftate BP | 1.000% w/w |
Chlorocresol BP (as preservative) | 0.100 % w/w |
Cream Base | Q. S. |
|
54 |
Clobetasol with
Miconazole Cream
(For Export) |
Each Composition Contains:
Clobetasol Propionate BP | 0.050% w/w |
Miconazole Nitrate BP | 2.000% w/w |
Cream Base | Q. S. |
|
55 |
Clobetasol, Gentamicin &
Miconazole Cream
(For Export) |
Each Composition Contains:
Clobetasol Propionate BP | 0.050% w/w |
Gentamicin Sulfate BP Eq. To Gentamicin | 0.100% w/w |
Miconazole Nitrate BP | 2.000% w/w |
Cream Base | Q. S. |
|
56 |
Clobetasol, Gentamicin &
Miconazole Cream
(For Export) |
Each Composition Contains:
Clobetasol Propionate BP | 0.050% w/w |
Gentamicin Sulfate BP Eq. To Gentamicin | 0.200% w/w |
Miconazole Nitrate BP | 2.000% w/w |
Cream Base | Q. S. |
|
57 |
Clobetasol, Gentamicin with
Clotrimazole & Miconazole
Cream (For Export) |
Each Composition Contains:
Clobetasol Propionate BP | 0.050% w/w |
Gentamicin Sulfate BP Eq. To Gentamicin | 0.100% w/w |
Miconazole Nitrate BP | 2.000% w/w |
Clotrimazole BP | 1.000% w/w |
Cream Base | Q. S. |
|
58 |
Fluocinolone ointment BP
0.025% w/w (For Export) |
Each Composition Contains:
Fluocinolone Acetonide BP | 0.025 % |
Ointment Base | Q. S. |
|
59 |
Fluocinolone with Neomycin &
Miconazole Cream
(For Export) |
Each Composition Contains:
Fluocinolone Acetonide BP | 0.100% w/w |
Neomycin Sulfate USP | 0.500% w/w |
Miconazole Nitrate BP | 2.000% w/w |
Cream Base | Q. S. |
|
60 |
Fluocinolone, Gentamicin &
Miconazole Cream
(For Export) |
Each Composition Contains:
Fluocinolone Acetonide BP | 0.010% w/w |
Gentamicin (as Gentamicin Sulfate BP) | 0.100% w/w |
Miconazole Nitrate BP | 2.000% w/w |
Cream Base | Q. S. |
|
61 |
Hydrocortisone Acetate
Cream BP 0.5 % w/w
(For Export) |
Each Composition Contains:
Hydrocortisone Acetate BP | 0.500% w/w |
Cream Base | Q. S. |
|
62 |
Hydroquinone, Tretinoin &
Mometasone Fuorate Gel
(For Export) |
Each Composition Contains:
Hydroquinone USP | 2.000% w/w |
Tretinoin USP | 0.025% w/w |
Mometasone Furoate BP | 0.100% w/w |
Gel Base | Q. S. |
|
63 |
Miconazole with Fluocinolone
Acetonide Cream
(For Export) |
Each Composition Contains:
Fluocinolone Acetonide BP | 0.025% w/w |
Miconazole Nitrate BP | 2.000% w/w |
Cream Base | Q. S. |
|
64 |
Miconazole with Fluocinolone
Acetonide Cream
(For Export) |
Each Composition Contains:
Fluocinolone Acetonide BP | 0.01% w/w |
Miconazole Nitrate BP | 2.000% w/w |
Cream Base | Q. S. |
|
65 |
Mometasone Fuorate Cream
USP 0.1 % w/w
(For Export) |
Each Composition Contains:
Mometasone Furoate USP | 0.100% w/w |
Cream Base | Q. S. |
|
66 |
Mometasone Furoate and
Fusidic Acid Cream
(For Export) |
Each Composition Contains:
Mometasone Furoate BP | 0.1 %w/w |
Fusidic Acid BP | 2 % w/w |
Cream Base | Q. S. |
|
67 |
Mometasone Furoate and
Fusidic Acid Ointment
(For Export) |
Each Composition Contains:
Mometasone Furoate BP | 0.1 %w/w |
Fusidic Acid BP | 2 % w/w |
Ointment Base | Q. S. |
|
68 |
Mupirocin Ointment BP
2% w/w (For Export) |
Each Composition Contains:
Mupirocin BP | 2 % w/w |
Ointment Base | Q. S. |
|
69 |
Nadifloxacin and
Mometasone Furoate Cream
(For Export) |
Each gm Contains:
Nadifloxacin | 10 mg |
Mometsone Furoate BP | 1 mg |
Cream Base | Q. S. |
|
70 |
Nadifloxacin Gel 1% w/w
(For Export) |
Each Composition Contains:
Nadifloxacin | 1% w/w |
Gel Base | Q. S. |
|
71 |
Nadifloxacin,
Miconazole Nitrate and
Mometasone Furoate Cream
(For Export) |
Each Composition Contains:
Nadifloxacin | 1% w/w |
Miconazole Nitrate BP | 2% w/w |
Mometasone Furoate BP | 0.1% w/w |
Cream Base | Q. S. |
|
72 |
Neomycin Sulfate Ointment
USP 0.5% w/w
(For Export) |
Each Composition Contains:
Neomycin Sulfate USP | 0.5 % w/w |
Eq. To Neomycin Base | 0.35% w/w |
Cream Base | Q. S. |
|
73 |
Ofloxacin Ornidazole,
Itraconazole & Clobetasol
Propionate cream
(For Export) |
Each Composition Contains:
Ofloxacin BP | 0.075 % w/w |
Ornidazole BP | 2.0 % w/w |
Itraconazole USP | 1% w/w |
Clobetasol Propionate BP | 0.05% w/w |
Methyl Paraben BP (As preservative) | 0.2% w/w |
Propylparaben BP (As preservative) | 0.2% w/w |
Cream Base | Q. S. |
|
74 |
Sertaconazole Nitrate Cream
2 % w/w (For Export) |
Each Composition Contains:
Sertaconazole Nitrate | BP 2% w/w |
Cream Base | Q. S. |
|
75 |
Ofloxacin, Ornidazole,
Terbinafine & Clobetasol
Propionate cream
(For Export) |
Each Composition Contains:
Ofloxacin BP | 0.075 % w/w |
Ornidazole BP | 2.0 % w/w |
Terbinafine Hydrochloride BP | 1% w/w |
Clobetasol Propionate BP | 0.05% w/w |
Methyl Paraben BP (As preservative) | 0.2% w/w |
Propylparaben BP (As preservative) | 0.2% w/w |
Cream Base | Q. S. |
|
76 |
Polymixin B Sulfate,
Bacitracin Zinc &
Neomycin Sulfate Cream
(For Export) |
Each gm Contains:
Polymixin B Sulfate | 5000 IU |
Bacitracin Zinc BP | 400 IU |
Neomycin Sulfate USP | 3400 IU |
Cream Base | Q. S. |
|
77 |
Terbinafine Hydrochloride
Cream 1% w/w
(For Export) |
Each Composition Contains:
Terbinafine Hydrochloride BP | 1% w/w |
Benzyl Alcohol BP (As preservative) | 1% w/w |
Cream Base | Q. S. |
|
78 |
Tetracycline Skin Ointment
1 % w/w (For Export) |
Each Composition Contains:
Tetracycline Hydrochloride BP | 1 % w/w |
Ointment Base | Q. S. |
|
79 |
Beclometasone with
Clioquinol Cream
(For Export) |
Each Composition Contains:
Beclometasone Dipropionate BP | 0.025% w/w |
Iodochlorhydroxyquinoline (Clioquinol) BP | 3.000% w/w |
Cream Base | Q. S. |
|
80 |
Clobetasol Propionate,
Gentamicin Sulfate, Tolnaftate,
Iodochlor hydroxyquinoline &
Clotrimazole Cream
(For Export) |
Each Composition Contains:
Clobetasol Propionate BP | 0.05% w/w |
Gentamicin Sulfate BP Eq. to Gentamicin | 0.1% w/w |
Tolnaftate BP | 1.0% w/w |
Iodochlorhydroxyquinoline BP | 1.0% w/w |
Clotrimazole BP | 1.0% w/w |
Cream Base | Q. S. |
|
81 |
Clobetasol Propionate,
Neomycin Sulfate and
Miconazole Nitrate &
Zinc Sulfate cream
(For Export) |
Each Composition Contains:
Clobetasol Propionate BP | 0.05% w/w |
Neomycin Sulfate USP Eq. To Neomycin | 0.5% w/w |
Miconazole Nitrate BP | 2% w/w |
Zinc Sulfate Monohydrate BP | 0.1% w/w |
Cream Base | Q. S. |
|
82 |
Hydrocortisone Acetate
Cream BP 1%w/w
(For Export) |
Each Composition Contains:
Hydrocortisone Acetate BP | 1.00% w/w |
Cream Base | Q. S. |
|
83 |
Clobetasol Propionate,
Neomycin Sulfate and
Miconazole Nitrate cream
(For Export) |
Each Composition Contains:
Clobetasol Propionate BP | 0.05 w/w |
Neomycin Sulfate USP Eq. To Neomycin | 0.5 w/w |
Miconazole Nitrate BP | 2.00 w/w |
Chlorocresol BP (As preservative) | 0.1% w/w/td> |
Cream Base | Q. S. |
|
84 |
Beclomethasone Dipropionate,
Neomycin Sulfate and
Clotrimazole Cream
(For Export) |
Each Composition Contains:
Beclomethasone Dipropionate USP | 0.025% w/w |
Neomycin Sulfate USP | 0.5% w/w |
Eq. to Neomycin Base | 0.35% w/w |
Clotrimazole BP | 1.0% w/w |
Cream Base | Q. S. |
|
85 |
Beclomethasone Dipropionate,
Neomycin Sulfate and
Miconazole Nitrate Cream
(For Export) |
Each Composition Contains:
Beclomethasone Dipropionate USP | 0.025% w/w |
Neomycin Sulfate USP | 0.5% w/w |
Eq. to Neomycin Base | 0.35% w/w |
Miconazole Nitrate | 2.0% w/w |
Cream Base | Q. S. |
|
86 |
Luliconazole Cream 1% w/w
(For Export) |
Each Composition Contains:
Luliconazole | 1% w/w |
Cream Base | Q. S. |
|